Assessment of prognostic factors in epithelial ovarian cancer

ÖNAL Y., KÖSTEK O., HACIOĞLU M. B., ERDOĞAN B., KODAZ H., TÜRKMEN BEKMEZ E., ...Daha Fazla

EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, cilt.1, sa.2, ss.61-68, 2017 (Hakemli Dergi) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 1 Sayı: 2
  • Basım Tarihi: 2017
  • Doi Numarası: 10.14744/ejmo.2017.43531
  • Dergi Adı: EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY
  • Derginin Tarandığı İndeksler: Other Indexes
  • Sayfa Sayıları: ss.61-68
  • Anahtar Kelimeler: Chemotherapy, mortality, ovarian cancer, prognosis, residual tumor, STAGE-III, PHASE-III, FOLLOW-UP, SURVIVAL, SURGERY, RISK, CARCINOMA, THERAPY, ASCITES, CYCLOPHOSPHAMIDE
  • Marmara Üniversitesi Adresli: Hayır

Özet

Objectives: Ovarian cancer is the second most common gynecological cancer, and has a 5-year survival rate of about 40% to 45%. This ratio ranges from 15% to 95%, based on prognostic factors. There are numerous clinical, pathological and biological factors related to prognosis. The aim of this study was to assess prognostic factors in advanced epithelial ovarian cancer.